IRTC iRhythm Technologies, Inc. Insider Trading

iRhythm CFO Wilson Daniel G. sold 8,000 shares at $207.44 for $1.7M, reducing holdings by 23.2% to 26.5K shares.

CFO Wilson Daniel G. executed a substantial open-market sale of 8,000 shares at $207.44 on 2025-10-31, reducing his holdings from 34.5K to 26.5K shares (a 23.2% reduction). The stock currently trades at $185.00, down from the $207.44 transaction price. iRhythm is a $6.0B market-cap company experiencing strong revenue growth (+20.1% annually) but remains unprofitable, with a $-5.2M net loss in the latest quarter on $192.9M revenue. The sale represents a discrete reduction in the insider's position rather than a routine rebalancing; however, without a 10b5-1 trading plan FLAG, transaction timing cannot be assessed for pattern significance. The cross-ticker track record shows only 1 prior sell with a 30-day return of +0.4%, and the single measurable prior IRTC trade (a sell on 2025-09-03) also posted +0.4% over 30 days—insufficient data to establish a timing pattern at this ticker.

CFO Wilson Daniel G. sold 5,000 IRTC shares at $175.00 on 2025-09-03; holds 34,470 shares post-transaction.

Wilson Daniel G., serving as Chief Financial Officer, disposed of 5,000 shares (12.7% of pre-transaction holdings) at $175.00 per share for total proceeds of $875,000.00. This sale occurred as iRhythm's stock trades near its 52-week high of $182.17 and has posted strong momentum (+13.6% over 30 days, +24.2% over 90 days), suggesting the transaction did not occur against a backdrop of weakness or price deterioration. The company itself remains unprofitable (net income of $-14.2M in the latest full fiscal year) despite solid revenue growth of +20.1% year-over-year and quarterly revenue of $186.7M, which investors should weigh when evaluating the broader operational trajectory. The sale materially reduces the CFO's direct equity stake in the company while the stock remains near historical highs.

CEO Blackford sells 30,000 IRTC shares across 7 transactions for $4.8M at blended $160.54; holds 179.0K post-sale

Blackford Quentin S., President and CEO of iRhythm Technologies, executed 7 separate sales totaling 30,000 shares for $4,816,191.46 on 2025-08-05, reducing holdings by 14.4%. The transactions occurred at prices ranging from $158.85 to $165.00, with a blended average of $160.54, during a period when the stock has risen 12.1% over 30 days and 13.9% over 90 days. The company's latest quarter showed revenue of $186,687,000 but net income of $-14,218,000, reflecting ongoing unprofitability despite 20.1% annual revenue growth. Across his prior trades at IRTC (4 prior sells), only 1 of 4 was well-timed at the 90-day mark, with most recent sells (2025-03-03 and 2025-02-26) followed by gains of 29.2% and 30.5% respectively. The current stock price of $156.02 is 5.4% below the 52-week high and sits near the transaction execution range, limiting immediate price-action perspective.

CCO Patterson sells 8,510 shares at avg $120.55 as IRTC hits 52-week high of $135.76; post-sale holdings 49,930 shares

Patterson Chad, Chief Commercial Officer of iRhythm Technologies, executed 2 separate sales totaling 8,510 shares for $1,025,897.50 on May 2, 2025 at an average price of $120.55, reducing his stake by 14.6% to 49,930 shares. This sale occurred as the stock reached its 52-week high of $135.76 (15 cents above the prior peak), reflecting a significant 35.3% gain over the preceding 30 days and 22.5% over 90 days. Patterson's cross-ticker track record shows 3 prior open-market sells with a 100.00% well-timed rate and -7.4% average 30-day return, suggesting a pattern of selling into strength; however, at IRTC specifically, his 2 most recent sells (February 2025) have not yet accumulated sufficient time to measure 90-day outcomes. The company remains unprofitable (net income -$30.7M on $158.7M quarterly revenue) despite 20.1% annual revenue growth, creating a backdrop where insider liquidation into a 52-week peak warrants attention to conviction levels and near-term momentum expectations.

Director Talwalkar buys 6,664 shares of IRTC at $75.16; holdings increase 54.3% to 18,941 shares

Director Abhijit Talwalkar purchased 6,664 shares at $75.16 on 2024-11-04, growing his stake by 54.3% from 12,277 to 18,941 shares and investing $500,866.24 in the transaction. This material increase in board-level ownership occurs in a company that reported a net loss of $-46,182,000.00 in its most recent full fiscal year despite achieving annual revenue growth of +19.9%, suggesting the business is scaling but not yet profitable. The stock has rebounded significantly over 30 days (+38.2%) from its 52-week lows but remains 29.9% below its 52-week high of $123.61, placing the director's entry point near the lower-middle range of recent trading activity. The substantial commitment of capital by a board member alongside the company's still-unprofitable financial position creates a focal point for investors assessing both management confidence and the timeline to profitability.

CCO Patterson Chad bought 280 shares of IRTC at $74.98 on 2024-05-31 for $20,994.40

Patterson Chad, Chief Commercial Officer at iRhythm Technologies, purchased 280 shares at $74.98 on 2024-05-31, increasing his holdings from 39,865 to 40,145 shares. The purchase represents a modest 0.7% addition to his existing position. As a CCO, this transaction occurs within the natural context of an executive maintaining ownership in the company; however, the relatively small dollar amount ($20,994.40) and incremental share increase provide limited insight into conviction-level or strategic intent regarding the stock's valuation.